Diabetes News and Research

Latest Diabetes News and Research

Study presents new technique that makes drug testing possible through exhaled air

A new study from the Swedish medical university Karolinska Institutet presents a new technique that makes drug testing possible through exhaled air for the first time. By examining people who had received emergency care for an amphetamine overdose, the researchers found that in all cases there were traces of amphetamine and metamphetamine in the exhaled breath.

19 May 2010

Global Health Partner inaugurates own clinic for obesity and metabolic disorders in Prague

Global Health Partner has inaugurated its own clinic for the treatment of obesity and metabolic disorders in Prague and the first obesity operations have been performed. The Czech Republic has a well insured population where patient flows are directed to clinics with strong medical results. "The Czech Republic is one of the markets that we have identified as interesting.

19 May 2010

Vaccinations recommended for adults

Yearly vaccinations aren't just for kids any more. You probably heard a lot about a seasonal or H1N1 flu shot last fall, but you should know that a battery of other adult vaccinations might also become part of your health care routine. Pneumonia and shingles vaccines are preventive-care essentials for older adults, and meningitis and tetanus shots are now college rites of passage. Even the vaccines of childhood—measles, mumps and rubella, and whooping cough—are recommended for adults who missed out in their younger years.

19 May 2010

Significant proportion of men with ED exhibit early signs of CAD: Review

International experts are calling for all men experiencing impotence to undergo thorough medical assessments, after an extensive review showed that a significant proportion of men with erectile dysfunction exhibit early signs of coronary artery disease.

19 May 2010

Tel Aviv University researcher develops tool to measure tissue damage in bed-ridden, paralyzed patients

There's currently no reliable tool to help prosthetic developers fit artificial limbs without ensuing discomfort or pain, or tell medical personnel when bed-ridden patients need to be moved to avoid bedsores and other problems.

19 May 2010

Diabetic patients with limited health literacy are at higher risk for hypoglycemia: Study

People with diabetes who have limited health literacy are at higher risk for hypoglycemia or low blood sugar, according to a new study from researchers at the University of California, San Francisco and the Kaiser Permanente Division of Research in Oakland, CA.

19 May 2010

Two common operations for SUI help women achieve similar levels of dryness: Study

Two common operations for stress urinary incontinence help women achieve similar levels of dryness, according to a team of urologists and urogynecologists who compared the treatments in a large U.S. trial supported by the National Institutes of Health. The study is being released online May 17, 2010, by the New England Journal of Medicine to coincide with a presentation at the annual meeting of the American College of Obstetrics and Gynecology. Results will appear in the June 3 print edition.

19 May 2010

Generex Biotechnology's Phase I study data of AE37 for prostate cancer published

Generex Biotechnology Corporation announced today publication of results from the first Phase I study of its lead immunotherapeutic agent AE37 in patients with prostate cancer. At the end of 2009, the Company announced positive interim results from a Phase II trial being conducted with AE37 in patients with breast cancer. The compound is being developed by its wholly-owned subsidiary, Antigen Express, Inc.

19 May 2010

Roche Diagnostics, ACC collaborate to develop biomarkers clinical resource Web portal

Roche Diagnostics and the American College of Cardiology have begun a unique collaboration to develop a peer-reviewed biomarkers clinical resource Web portal.

From Roche Sequencing and Life Science 19 May 2010

Roche, Biogen Idec discontinue ocrelizumab clinical development programme for RA

Roche and Biogen Idec today announced their decision to discontinue the ocrelizumab clinical development programme in patients with rheumatoid arthritis (RA).

19 May 2010

Cincinnati Children's Hospital Medical Center launches REGID

A new nationwide registry will allow researchers to conduct larger, more effective studies of often misdiagnosed disorders that affect thousands of children in the United States.

19 May 2010

30 percent risk of heart attack in Australians over 55

According to a new study researchers have warned that at least one in five Australians over the age of 55 have a 30 percent chance of suffering a potentially fatal heart attack or stroke in the next five years.

18 May 2010

Harbor BioSciences announces presentation of new data from Apoptone Phase I/IIa trial at ASCO Annual Meeting

Harbor BioSciences, Inc. today announced that new data from the Phase I/IIa clinical trial of the company's lead drug candidate Apoptone®, its anticancer drug candidate being developed for prostate cancer, will be presented as part of the Scientific Program in a General Poster Session at the American Society of Clinical Oncology (ASCO) Annual Meeting.

18 May 2010

Jonas Brothers help raise funds for Childrens Hospital Los Angeles during Rock For Diabetes event

The multi-platinum album selling and Grammy nominated music artists, Jonas Brothers, joined more than 200 guests at the home of Danny DeVito and Rhea Perlman on Sunday, May 16 during the annual "Rock For Diabetes" event, to help raise funds for the Center for Endocrinology, Diabetes and Metabolism at Childrens Hospital Los Angeles. Performing a special live show for attendees, the event raised more than $250,000 for the Center.

18 May 2010

Adults with newly diagnosed type 1 diabetes recruited for Protege Encore clinical trial

Dr. Bruce Bode announced today that he is now recruiting adults with newly diagnosed type 1 diabetes for Protege Encore, a randomized, placebo-controlled Phase III clinical trial. This is the second of two Phase III studies testing the safety and efficacy of an investigational drug called teplizumab. The first study, known as Protege, has completed enrollment of more than 530 subjects with type 1 diabetes.

18 May 2010

Benefits of aerobic training outclass those of lower-intensity walking programs

What to do: walk around the block or work up a sweat in an aerobic workout at the gym? If you're looking for the best health benefits from an exercise program, a traditional aerobic fitness program that gets your heart pumping beats a walking program hands down. But if you want to get moving, a walking program is easier to do, it's good for you, and you're more likely to stick with it.

18 May 2010

IDEV launches SUPERA VERITAS Peripheral Vascular System in Europe

IDEV Technologies, Incorporated, (IDEV) an emerging leader in the development and marketing of minimally invasive medical technologies, today announced the European launch of the SUPERA VERITAS™ Peripheral Vascular System, a novel and innovative stent delivery system designed to be reliable, easy to use and precise. The SUPERA VERITAS system was formally launched in the first quarter of 2010 at the Leipzig Interventional Course (LINC) 2010 conference in Leipzig, Germany.

18 May 2010

IMUC, Torrey Pines Institute identify peptides that generate CD-133 specific T-cells

ImmunoCellular Therapeutics, a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that the Company and Torrey Pines Institute for Molecular Studies in San Diego, CA have identified several peptides which can generate CD-133 specific T-cells. CD-133 is found in high abundance on cancer stem cells ("CSCs") which makes it promising for immunological targeting.

18 May 2010

Pfizer, Washington University announce indications discovery collaboration

In a first-of-a-kind collaboration between academia and industry, Pfizer Inc. will give scientists at Washington University School of Medicine in St. Louis unprecedented access to information regarding more than 500 pharmaceuticals and pharmaceutical candidates in a partnership that focuses on discovering new uses for existing compounds.

18 May 2010

University of Leeds researchers identify natural defence mechanism against heart disease

A natural defence mechanism against heart disease could be switched on by steroids sold as health supplements, according to researchers at the University of Leeds.

18 May 2010

Diabetes News and Research

Latest Diabetes News and Research

Study presents new technique that makes drug testing possible through exhaled air

Global Health Partner inaugurates own clinic for obesity and metabolic disorders in Prague

Vaccinations recommended for adults

Significant proportion of men with ED exhibit early signs of CAD: Review

Tel Aviv University researcher develops tool to measure tissue damage in bed-ridden, paralyzed patients

Diabetic patients with limited health literacy are at higher risk for hypoglycemia: Study

Two common operations for SUI help women achieve similar levels of dryness: Study

Generex Biotechnology's Phase I study data of AE37 for prostate cancer published

Roche Diagnostics, ACC collaborate to develop biomarkers clinical resource Web portal

Roche, Biogen Idec discontinue ocrelizumab clinical development programme for RA

Cincinnati Children's Hospital Medical Center launches REGID

30 percent risk of heart attack in Australians over 55

Harbor BioSciences announces presentation of new data from Apoptone Phase I/IIa trial at ASCO Annual Meeting

Jonas Brothers help raise funds for Childrens Hospital Los Angeles during Rock For Diabetes event

Adults with newly diagnosed type 1 diabetes recruited for Protege Encore clinical trial

Benefits of aerobic training outclass those of lower-intensity walking programs

IDEV launches SUPERA VERITAS Peripheral Vascular System in Europe

IMUC, Torrey Pines Institute identify peptides that generate CD-133 specific T-cells

Pfizer, Washington University announce indications discovery collaboration

University of Leeds researchers identify natural defence mechanism against heart disease

Genomics - Industry Focus eBook (2nd edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Diabetes News and Research

Latest Diabetes News and Research

Genomics - Industry Focus eBook (2nd edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in